Biotronik has received FDA approval for its first bare-metal stent for coronary arteries. The device is intended for patients with new and recurring blockages in the coronary arteries between 2.25 and 4.0 mm in diameter and lesion lengths up to 31 mm. The PRO-Kinetic Energy Cobalt Chromium Bare-Metal Stent was tested in a global trial of 329 patients. The approval is a milestone for Biotronik as the device will be the first U.S. marketing Biotronik coronary stent. Read the full statement here.